Heart Attack News and Research

RSS

Aspirin to be tested as a potential COVID-19 treatment as part of RECOVERY trial

Now, in new research, the everyday painkiller aspirin will be evaluated as a potential treatment for COVID-19 in one of the United Kingdom’s most significant trials, aiming to evaluate whether it can reduce the risk of blood clots in infected people.

9 Nov 2020

Researchers identify new strategy to combat loss of skeletal muscle mass

Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that stimulating expression of a protein naturally produced by the human body can be a strategy to combat loss of skeletal muscle mass, which happens normally with aging but can intensify in cases of neurodegenerative or inflammatory disease, or in patients who spend long periods in intensive care units (ICUs).

9 Nov 2020

Children with Kawasaki Disease at increased risk for cardiovascular events 10 years later

New research shows that children with Kawasaki Disease remain at an increased risk for cardiovascular events more than 10 years after hospitalization for their condition, highlighting the need for long-term heart disease surveillance and risk reduction strategies for these young patients.

6 Nov 2020

Black patients with lupus have higher risk of stroke and ischemic heart disease

New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.

6 Nov 2020

Study describes the effects of a DPP3-knockout on the renin-angiotensin system

The role of the enzyme dipeptidyl peptidase 3 in the blood pressure-regulating renin-angiotensin system was investigated in the inter-university cooperation project BioTechMed-Graz. The results could pave the way for new therapies for cardio-renal diseases.

5 Nov 2020

Rubbery bioelectronic cardiac patch can monitor and treat heart disease

Pacemakers and other implantable cardiac devices used to monitor and treat arrhythmias and other heart problems have generally had one of two drawbacks - they are made with rigid materials that can't move to accommodate a beating heart, or they are made from soft materials that can collect only a limited amount of information.

3 Nov 2020

New dataset can help analyze multiple storms, track health outcomes

Hurricanes and other tropical cyclones can severely impact human health in communities across the country, but data for these events is limited, especially in a format that is easy to link with human health outcomes.

29 Oct 2020

CAC scanning can help doctors decide which patients might benefit from aspirin therapy

An X-ray test commonly used to assess hardening of the arteries could help doctors decide whether the benefits of taking aspirin to prevent a first heart attack or stroke outweigh the risks of bleeding from its use, UT Southwestern research suggests.

28 Oct 2020

Studies suggest the need for a new home-time metric to judge hospital readmissions

Two new studies suggest Medicare's system of penalizing hospitals if too many patients are readmitted within 30 days should also look at whether the patients were well enough to remain in their home during that time.

28 Oct 2020

Novel cardiac patch improves recovery from heart attack in rats and pigs

According to the American Heart Association, heart disease is the leading cause of death worldwide in recent years.

28 Oct 2020

Foods rich in omega-3 EPA & ALA improve outcomes in people who suffered serious heart attack

A new study published in the Journal of the American College of Cardiology found that regular consumption of foods rich in omega-3 eicosapentaenoic acid (EPA), found in marine foods like fatty fish, and alpha-linolenic acid (ALA), found in plant foods like walnuts, was associated with improved outcomes in individuals who suffered a heart attack, including decreased risk of death.

28 Oct 2020

WSU research sheds new light on a drug that may be used to treat hypertrophic cardiomyopathy

Research at Washington State University sheds new light on one molecule that may be used to treat a heart condition that can lead to stroke, heart attack and other forms of heart disease.

27 Oct 2020

Omega-3 rich foods improve prognosis in patients with myocardial infarction

A team of researchers from the Germans Trias i Pujol Hospital and Research Institute and the Hospital del Mar Medical Research Institute has shown that regularly consuming foods rich in omega-3 fatty acids, from both animal and vegetable origins, strengthens the heart's membranes and helps improve the prognosis in the event of a myocardial infarction.

27 Oct 2020

Study identifies cardiac structural damage experienced by COVID-19 patients

Cardiac ultrasounds (also known as echocardiograms) are providing a view of the heart and the impact of the COVID-19 virus on patients.

27 Oct 2020

Aspirin use associated with reduced mortality risk in hospitalized COVID-19 patients

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine.

22 Oct 2020

Dolutegravir is a first-line treatment for people newly diagnosed with HIV

A new study by UBC researchers is set to change international treatment recommendations for people who are newly diagnosed with HIV--an update that could affect nearly two million people per year worldwide.

19 Oct 2020

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

The National Foundation for Infectious Diseases (NFID) issued a new Call to Action report detailing the risks of co-infection with influenza (flu) and COVID-19 in adults with chronic health conditions, and the importance of flu vaccination during the 2020-2021 season.

16 Oct 2020

Researchers reveal potential mechanisms behind the healing power of extracellular vesicles

Extracellular vesicles (EVs) -- nanometer sized messengers that travel between cells to deliver cues and cargo -- are promising tools for the next generation of therapies for everything from autoimmune and neurodegenerative diseases to cancer and tissue injury.

15 Oct 2020

G protein-coupled receptors help humans taste, smell, and regulate mood and immunity

Dr. Guangyu Wu is dissecting the molecular homing that enables a nascent protein to ultimately find its way to the surface of a cell as a mature receptor type that helps us taste, smell and even regulate our mood and immunity.

14 Oct 2020

Study finds sex differences among young individuals who suffer a heart attack

Women aged 50 or younger who suffer a heart attack are more likely than men to die over the following 11 years, according to a new study published today (Wednesday) in the European Heart Journal.

13 Oct 2020

Heart Attack News and Research

Aspirin to be tested as a potential COVID-19 treatment as part of RECOVERY trial

Researchers identify new strategy to combat loss of skeletal muscle mass

Children with Kawasaki Disease at increased risk for cardiovascular events 10 years later

Black patients with lupus have higher risk of stroke and ischemic heart disease

Study describes the effects of a DPP3-knockout on the renin-angiotensin system

Rubbery bioelectronic cardiac patch can monitor and treat heart disease

New dataset can help analyze multiple storms, track health outcomes

CAC scanning can help doctors decide which patients might benefit from aspirin therapy

Studies suggest the need for a new home-time metric to judge hospital readmissions

Novel cardiac patch improves recovery from heart attack in rats and pigs

Foods rich in omega-3 EPA & ALA improve outcomes in people who suffered serious heart attack

WSU research sheds new light on a drug that may be used to treat hypertrophic cardiomyopathy

Omega-3 rich foods improve prognosis in patients with myocardial infarction

Study identifies cardiac structural damage experienced by COVID-19 patients

Aspirin use associated with reduced mortality risk in hospitalized COVID-19 patients

Dolutegravir is a first-line treatment for people newly diagnosed with HIV

NFID issues new report detailing risks of co-infection with flu and COVID-19 in vulnerable adults

Researchers reveal potential mechanisms behind the healing power of extracellular vesicles

G protein-coupled receptors help humans taste, smell, and regulate mood and immunity

Study finds sex differences among young individuals who suffer a heart attack

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News